Journal article icon

Journal article

Altitude sickness in climbers and efficacy of NSAIDs trial (ASCENT): Randomized, controlled trial of ibuprofen versus placebo for prevention of altitude illness

Abstract:

Objective: To study the effectiveness of ibuprofen versus placebo in preventing acute mountain sickness (AMS) and high altitude headache (HAH). Methods: Double-blind, randomized, placebo-controlled trial. Results: Two hundred ninety-four healthy Western trekkers were recruited on the Everest approach at 4280 m or 4358 m and randomly assigned to receive either 600 mg of ibuprofen or placebo 3 times daily before and during ascent to 4928 m. One hundred eighty-three of 294 participants completed...

Expand abstract

Actions


Access Document


Publisher copy:
10.1016/j.wem.2012.08.001

Authors


Journal:
Wilderness and Environmental Medicine More from this journal
Volume:
23
Issue:
4
Pages:
307-315
Publication date:
2012-12-01
DOI:
ISSN:
1080-6032
Language:
English
Keywords:
Pubs id:
pubs:366747
UUID:
uuid:fcecdf9d-180b-480d-9f6b-b820291ad93b
Local pid:
pubs:366747
Source identifiers:
366747
Deposit date:
2013-11-17

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP